The October edition of the Red Journal #AJRCMB is now available. academic.oup.com/ajrcmb/issue... #lungdisease #asthma #CF #Influenza @atscommunity.bsky.social

The October edition of the Red Journal #AJRCMB is now available. academic.oup.com/ajrcmb/issue... #lungdisease #asthma #CF #Influenza @atscommunity.bsky.social
I was delighted to chair a patient centred Studio Session for @europeanlung.bsky.social focused on #HolisticCare in #LungDisease at the recent @europeanrespsoc.bsky.social Congress in #Barcelona
New hope for IPF patients: landmark trial shows a novel therapy can slow lung function decline in idiopathic pulmonary fibrosis. Published in NEJM July 202… #Antifibrotictherapy #Idiopathicpulmonaryfibrosis #IPFtreatment #Lungdisease #NEJM2026 #Antifibrotictherapy #Idiopathicpulmonaryfibrosis #…
@astrazeneca.com's drug scores two late-stage trial wins as full data boosts blockbuster hopes
Two international #ClinicalTrials found that the investigational #BiologicTherapy #tozorakimab significantly reduced #COPD flare-ups in patients receiving standard treatment.
#LungDisease
Drug developed for lung disease may slow biological aging in surprising ‘bonus’
replaye.com/drug-develop...
"A review of news articles and interview transcripts in the days and weeks after Sept. 11 shows that Mr. Giuliani continued to vouch for the safety of the air quality" despite reports stating otherwise. Bloomberg also offered assurances.